REQUEST A DEMO
Total
USD $0.00
Search more companies

CASA-PHARMA Zrt. (Hungary)

Main Activities: Real Estate
Full name: CASA-PHARMA Zrt. Profile Updated: August 16, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English & Hungarian Download a sample report

CASA-PHARMA Zrt. is based in Hungary, with the head office in Budapest. The company operates in the Real Estate sector. It was incorporated on January 16, 2012. The total number of employees is currently 1 (2023). From the latest financial highlights, CASA-PHARMA Zrt. reported a net sales revenue drop of 5.68% in 2022. There was a total growth of 228.44% in CASA-PHARMA Zrt.’s total assets over the same period. In 2022, CASA-PHARMA Zrt.’s net profit margin increased by 5.69%.

Headquarters
Istenhegyi ut 70. B. ep. I. emelet 1.
Budapest; Budapest; Postal Code: 1125

Contact Details: Purchase the CASA-PHARMA Zrt. report to view the information.

Basic Information
Total Employees:
Purchase the CASA-PHARMA Zrt. report to view the information.
Outstanding Shares:
Purchase the CASA-PHARMA Zrt. report to view the information.
Registered Capital:
Purchase the CASA-PHARMA Zrt. report to view the information.
Incorporation Date:
January 16, 2012
Key Executives
Purchase this report to view the information.
Chief Executive Officer
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Subsidiaries
DOME TRADE Szolgaltato Kft.
Solarfarm-Halas Kft.
Valibi News 2018 Kft.
Company Performance
Financial values in the chart are available after CASA-PHARMA Zrt. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency HUF. Absolute financial data is included in the purchased report.
Net sales revenue
-5.68%
Total operating revenue
-20.21%
Operating profit (EBIT)
34.54%
EBITDA
39.58%
Net Profit (Loss) for the Period
26.19%
Total assets
228.44%
Total equity
140.94%
Operating Profit Margin (ROS)
7.22%
Net Profit Margin
5.69%
Return on Equity (ROE)
-39.45%
Quick Ratio
-0.76%
Cash Ratio
-0.13%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?